4 Min Read NEW DELHI (Reuters) - India said on Wednesday its coronavirus immunisation campaign would continue with “full rigour” despite some concerns in Europe about the safety of the AstraZeneca vaccine it relies heavily upon as infections hit a three month high. A health worker checks the temperature of a passenger, amid the spread of the coronavirus disease (COVID-19), at a railway station in Mumbai, India, March 17, 2021. REUTERS/Francis Mascarenhas The European Medicines Agency is investigating reports of 30 cases of unusual blood disorders out of 5 million recipients of the vaccine...